Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of Intragastric Balloon on Bone, Metabolic and Respiratory Parameters

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2012 by Universidade Federal do Rio de Janeiro.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Miguel Madeira, Federal University of Rio de Janeiro Identifier:
First received: May 4, 2012
Last updated: May 15, 2012
Last verified: May 2012

The purpose of this study is to evaluate the effects of intragastric balloon on bone, metabolic and respiratory parameters in 50 patients with metabolic syndrome.

Condition Intervention Phase
Metabolic Syndrome
Device: Silimed Intragastric balloon
Phase 3

Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effects of Intragastric Balloon on Bone, Metabolic and Respiratory Parameters

Resource links provided by NLM:

Further study details as provided by Universidade Federal do Rio de Janeiro:

Primary Outcome Measures:
  • Change in bone mineral density and body composition [ Time Frame: Baseline and 6 months ] [ Designated as safety issue: No ]
    Bone mineral density and body composition by dual-energy X-ray absorptiometry (DXA)

  • Change in fasting and postprandial glucose [ Time Frame: Baseline and 6 months ] [ Designated as safety issue: No ]
  • Change in Pulmonary function tests [ Time Frame: Baseline and 6 months ] [ Designated as safety issue: No ]
    Pulmonary function tests consiste of spirometry, body plethysmograph, diffusing capacity for carbon monoxide (DLco), and respiratory muscle strength. Measurements are conducted using the Collins Plus Pulmonary Function Testing Systems (Warren E. Collins, Inc., Braintree, MA, USA).

  • Change in bone microarchitecture [ Time Frame: Baseline and 6 months ] [ Designated as safety issue: No ]
    Bone microarchitecture by high-resolution peripheral quantitative computed tomography

  • Change in lipid profile [ Time Frame: Baseline and 6 months ] [ Designated as safety issue: No ]
    Total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol

Estimated Enrollment: 50
Study Start Date: March 2011
Estimated Study Completion Date: August 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Silimed Intragastric balloon
    Intragastric balloon inflated with 650 ml of NaCl 0.9% mixed with 20 ml of methylene blue solution

Ages Eligible for Study:   20 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • metabolic syndrome (IDF criteria)

Exclusion Criteria:

  • menopause
  • older than 50 years
  • diabetes mellitus
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01598233

Universidade Estadual do Rio de Janeiro
Rio de Janeiro, Brazil, 20.551-030
Sponsors and Collaborators
Universidade Federal do Rio de Janeiro
  More Information

No publications provided

Responsible Party: Miguel Madeira, Principal investigator, Federal University of Rio de Janeiro Identifier: NCT01598233     History of Changes
Other Study ID Numbers: 3056-CEP/HUPE
Study First Received: May 4, 2012
Last Updated: May 15, 2012
Health Authority: Brazil: Associação Fundo de Incentivo à Pesquisa

Additional relevant MeSH terms:
Metabolic Syndrome X
Body Weight
Glucose Metabolism Disorders
Insulin Resistance
Metabolic Diseases
Signs and Symptoms processed this record on November 27, 2014